Review



pantoprazole sulfone  (Toronto Research Chemicals)


Bioz Verified Symbol Toronto Research Chemicals is a verified supplier
Bioz Manufacturer Symbol Toronto Research Chemicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Toronto Research Chemicals pantoprazole sulfone
    Mean plasma <t>pantoprazole</t> concentration (logarithmic scale) vs. time (hr) profiles for neonatal calves ( n = 9) following intravenous (IV) single dose administration of 1.0 mg/kg of pantoprazole.
    Pantoprazole Sulfone, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/imp/Pantoprazole+Sulfone/pmc07728716-141-0-2
    Average 93 stars, based on 5 article reviews
    pantoprazole sulfone - by Bioz Stars, 2026-11
    93/100 stars

    Images

    1) Product Images from "Pharmacokinetics and Tissue Levels of Pantoprazole in Neonatal Calves After Intravenous Administration"

    Article Title: Pharmacokinetics and Tissue Levels of Pantoprazole in Neonatal Calves After Intravenous Administration

    Journal: Frontiers in Veterinary Science

    doi: 10.3389/fvets.2020.580735

    Mean plasma pantoprazole concentration (logarithmic scale) vs. time (hr) profiles for neonatal calves ( n = 9) following intravenous (IV) single dose administration of 1.0 mg/kg of pantoprazole.
    Figure Legend Snippet: Mean plasma pantoprazole concentration (logarithmic scale) vs. time (hr) profiles for neonatal calves ( n = 9) following intravenous (IV) single dose administration of 1.0 mg/kg of pantoprazole.

    Techniques Used: Clinical Proteomics, Concentration Assay

     Pantoprazole  pharmacokinetic parameters following a single intravenous (1 mg/kg) administration to neonatal Holstein calves.
    Figure Legend Snippet: Pantoprazole pharmacokinetic parameters following a single intravenous (1 mg/kg) administration to neonatal Holstein calves.

    Techniques Used:

    Tissue concentrations of  pantoprazole sulfone  (μg/g) in collected tissues 1, 3, and 5 days after intravenous administration of pantoprazole (1 mg/kg) from study calves.
    Figure Legend Snippet: Tissue concentrations of pantoprazole sulfone (μg/g) in collected tissues 1, 3, and 5 days after intravenous administration of pantoprazole (1 mg/kg) from study calves.

    Techniques Used:

    Comparisons of pharmacokinetic parameters of  pantoprazole  in domestic animal species, after single dose intravenous administration.
    Figure Legend Snippet: Comparisons of pharmacokinetic parameters of pantoprazole in domestic animal species, after single dose intravenous administration.

    Techniques Used:

    Related Articles

    Clinical Proteomics:

    Article Title: Pharmacokinetics and Tissue Levels of Pantoprazole in Neonatal Calves After Intravenous Administration
    Article Snippet: Therefore, all the tissue samples were re-extracted as outlined previously in our methods.Therefore, all the tissue samples were re-extracted as outlined previously in our methods.. Pantoprazole sulfone (Toronto Research Chemicals, Ontario, Canada) became the analyte spiked into blank tissue samples to generate calibration spikes and QC samples.. Parallel reaction monitoring in the positive electrospray ion mode was used for analyte detection.Parallel reaction monitoring in the positive electrospray ion mode was used for analyte detection.

    Article Title: Stability of pantoprazole sodium in glass vials, polyvinyl chloride minibags, and polypropylene syringes.
    Article Snippet: The sensitivity of the assay was also determined.The sensitivity of the assay was also determined.. Five known degradation or impurity products of pantoprazole sodium (all obtained from Toronto Research Chemicals Inc) were analyzed for potential interference with the parent compound: pantoprazole N-oxide (catalogue no. P183010, lot 11-AZC-121-1), pantoprazole sulphide (catalogue no. P183020, lot 11-SWM-22-1), pantoprazole sulphide N-oxide (catalogue no. P183030, lot 11-AZC-115-1), pantoprazole sulphone (catalogue no. P183015, lot 11-AZC-47-1), and pantoprazole sulphone N-oxide (catalogue no. P183013, lot 11-AZC-60-1).

    Article Title: Stability of Pantoprazole Sodium in Glass Vials, Polyvinyl Chloride Minibags, and Polypropylene Syringes
    Article Snippet: The sensitivity of the assay was also determined.The sensitivity of the assay was also determined.. Five known degradation or impurity products of pantoprazole sodium (all obtained from Toronto Research Chemicals Inc) were analyzed for potential interference with the parent compound: pantoprazole N -oxide (catalogue no. P183010, lot 11-AZC-121-1), pantoprazole sulphide (catalogue no. P183020, lot 11-SWM-22-1), pantoprazole sulphide N -oxide (catalogue no. P183030, lot 11-AZC-115-1), pantoprazole sulphone (catalogue no. P183015, lot 11-AZC-47-1), and pantoprazole sulphone N -oxide (catalogue no. P183013, lot 11-AZC-60-1).

    Article Title: Stability of Pantoprazole Sodium in Glass Vials, Polyvinyl Chloride Minibags, and Polypropylene Syringes
    Article Snippet: The sensitivity of the assay was also determined.The sensitivity of the assay was also determined.. Five known degradation or impurity products of pantoprazole sodium (all obtained from Toronto Research Chemicals Inc) were analyzed for potential interference with the parent compound: pantoprazole N -oxide (catalogue no. P183010, lot 11-AZC-121-1), pantoprazole sulphide (catalogue no. P183020, lot 11-SWM-22-1), pantoprazole sulphide N -oxide (catalogue no. P183030, lot 11-AZC-115-1), pantoprazole sulphone (catalogue no. P183015, lot 11-AZC-47-1), and pantoprazole sulphone N -oxide (catalogue no. P183013, lot 11-AZC-60-1).. Stability Study A single 5-mL sample was collected from each container (as described in the “Sample Preparation” section above) immediately after packaging and was placed into a clean glass test tube.Stability Study A single 5-mL sample was collected from each container (as described in the “Sample Preparation” section above) immediately after packaging and was placed into a clean glass..

    Concentration Assay:

    Article Title: Pharmacokinetics and Tissue Levels of Pantoprazole in Neonatal Calves After Intravenous Administration
    Article Snippet: Therefore, all the tissue samples were re-extracted as outlined previously in our methods.Therefore, all the tissue samples were re-extracted as outlined previously in our methods.. Pantoprazole sulfone (Toronto Research Chemicals, Ontario, Canada) became the analyte spiked into blank tissue samples to generate calibration spikes and QC samples.. Parallel reaction monitoring in the positive electrospray ion mode was used for analyte detection.Parallel reaction monitoring in the positive electrospray ion mode was used for analyte detection.

    Article Title: Stability of pantoprazole sodium in glass vials, polyvinyl chloride minibags, and polypropylene syringes.
    Article Snippet: The sensitivity of the assay was also determined.The sensitivity of the assay was also determined.. Five known degradation or impurity products of pantoprazole sodium (all obtained from Toronto Research Chemicals Inc) were analyzed for potential interference with the parent compound: pantoprazole N-oxide (catalogue no. P183010, lot 11-AZC-121-1), pantoprazole sulphide (catalogue no. P183020, lot 11-SWM-22-1), pantoprazole sulphide N-oxide (catalogue no. P183030, lot 11-AZC-115-1), pantoprazole sulphone (catalogue no. P183015, lot 11-AZC-47-1), and pantoprazole sulphone N-oxide (catalogue no. P183013, lot 11-AZC-60-1).

    Article Title: Stability of Pantoprazole Sodium in Glass Vials, Polyvinyl Chloride Minibags, and Polypropylene Syringes
    Article Snippet: The sensitivity of the assay was also determined.The sensitivity of the assay was also determined.. Five known degradation or impurity products of pantoprazole sodium (all obtained from Toronto Research Chemicals Inc) were analyzed for potential interference with the parent compound: pantoprazole N -oxide (catalogue no. P183010, lot 11-AZC-121-1), pantoprazole sulphide (catalogue no. P183020, lot 11-SWM-22-1), pantoprazole sulphide N -oxide (catalogue no. P183030, lot 11-AZC-115-1), pantoprazole sulphone (catalogue no. P183015, lot 11-AZC-47-1), and pantoprazole sulphone N -oxide (catalogue no. P183013, lot 11-AZC-60-1).

    Article Title: Stability of Pantoprazole Sodium in Glass Vials, Polyvinyl Chloride Minibags, and Polypropylene Syringes
    Article Snippet: The sensitivity of the assay was also determined.The sensitivity of the assay was also determined.. Five known degradation or impurity products of pantoprazole sodium (all obtained from Toronto Research Chemicals Inc) were analyzed for potential interference with the parent compound: pantoprazole N -oxide (catalogue no. P183010, lot 11-AZC-121-1), pantoprazole sulphide (catalogue no. P183020, lot 11-SWM-22-1), pantoprazole sulphide N -oxide (catalogue no. P183030, lot 11-AZC-115-1), pantoprazole sulphone (catalogue no. P183015, lot 11-AZC-47-1), and pantoprazole sulphone N -oxide (catalogue no. P183013, lot 11-AZC-60-1).. Stability Study A single 5-mL sample was collected from each container (as described in the “Sample Preparation” section above) immediately after packaging and was placed into a clean glass test tube.Stability Study A single 5-mL sample was collected from each container (as described in the “Sample Preparation” section above) immediately after packaging and was placed into a clean glass..

    High Performance Liquid Chromatography:

    Article Title: Pharmacokinetics and Tissue Levels of Pantoprazole in Neonatal Calves After Intravenous Administration
    Article Snippet: Therefore, all the tissue samples were re-extracted as outlined previously in our methods.Therefore, all the tissue samples were re-extracted as outlined previously in our methods.. Pantoprazole sulfone (Toronto Research Chemicals, Ontario, Canada) became the analyte spiked into blank tissue samples to generate calibration spikes and QC samples.. Parallel reaction monitoring in the positive electrospray ion mode was used for analyte detection.Parallel reaction monitoring in the positive electrospray ion mode was used for analyte detection.

    Article Title: Stability of pantoprazole sodium in glass vials, polyvinyl chloride minibags, and polypropylene syringes.
    Article Snippet: The sensitivity of the assay was also determined.The sensitivity of the assay was also determined.. Five known degradation or impurity products of pantoprazole sodium (all obtained from Toronto Research Chemicals Inc) were analyzed for potential interference with the parent compound: pantoprazole N-oxide (catalogue no. P183010, lot 11-AZC-121-1), pantoprazole sulphide (catalogue no. P183020, lot 11-SWM-22-1), pantoprazole sulphide N-oxide (catalogue no. P183030, lot 11-AZC-115-1), pantoprazole sulphone (catalogue no. P183015, lot 11-AZC-47-1), and pantoprazole sulphone N-oxide (catalogue no. P183013, lot 11-AZC-60-1).

    Article Title: Stability of Pantoprazole Sodium in Glass Vials, Polyvinyl Chloride Minibags, and Polypropylene Syringes
    Article Snippet: The sensitivity of the assay was also determined.The sensitivity of the assay was also determined.. Five known degradation or impurity products of pantoprazole sodium (all obtained from Toronto Research Chemicals Inc) were analyzed for potential interference with the parent compound: pantoprazole N -oxide (catalogue no. P183010, lot 11-AZC-121-1), pantoprazole sulphide (catalogue no. P183020, lot 11-SWM-22-1), pantoprazole sulphide N -oxide (catalogue no. P183030, lot 11-AZC-115-1), pantoprazole sulphone (catalogue no. P183015, lot 11-AZC-47-1), and pantoprazole sulphone N -oxide (catalogue no. P183013, lot 11-AZC-60-1).

    Article Title: Stability of Pantoprazole Sodium in Glass Vials, Polyvinyl Chloride Minibags, and Polypropylene Syringes
    Article Snippet: The sensitivity of the assay was also determined.The sensitivity of the assay was also determined.. Five known degradation or impurity products of pantoprazole sodium (all obtained from Toronto Research Chemicals Inc) were analyzed for potential interference with the parent compound: pantoprazole N -oxide (catalogue no. P183010, lot 11-AZC-121-1), pantoprazole sulphide (catalogue no. P183020, lot 11-SWM-22-1), pantoprazole sulphide N -oxide (catalogue no. P183030, lot 11-AZC-115-1), pantoprazole sulphone (catalogue no. P183015, lot 11-AZC-47-1), and pantoprazole sulphone N -oxide (catalogue no. P183013, lot 11-AZC-60-1).. Stability Study A single 5-mL sample was collected from each container (as described in the “Sample Preparation” section above) immediately after packaging and was placed into a clean glass test tube.Stability Study A single 5-mL sample was collected from each container (as described in the “Sample Preparation” section above) immediately after packaging and was placed into a clean glass..



    Similar Products

    94
    Jena Bioscience 6 metimp
    a . Size exclusion chromatography (SEC) trace (left) and Coomassie-stained gel of PPAT–NUDT5–AMP complex (right) used for cryo-EM analysis. b . Motion-corrected and denoised micrograph of PPAT–NUDT5–AMP complex. c . Representative 2D class averages for PPAT–NUDT5–AMP complex. Micrographs and 2D class averages from the <t>6-meTIMP</t> and 6-benzylTIMP datasets were highly similar to that of the AMP-bound dataset. d , e . SEC and Coomassie-stained gels of PPAT–NUDT5 complexes formed in the presence of d . 6-meTIMP and e . 6-benzylTIMP. f . Cryo-EM data processing particle flow for the three nucleotide-bound PPAT–NUDT5 structures. All processing steps were performed in cryoSPARC. g – i . Angular distribution of particles and FSC curves from refinements of PPAT–NUDT5–purine complexes with g . AMP, h . 6-meTIMP and i . 6-benzylTIMP.
    6 Metimp, supplied by Jena Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/imp/6-Methylthio-IMP/pmc13421311-381-45-46
    Average 94 stars, based on 1 article reviews
    6 metimp - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    imp 3  (Bioss)
    94
    Bioss imp 3
    a . Size exclusion chromatography (SEC) trace (left) and Coomassie-stained gel of PPAT–NUDT5–AMP complex (right) used for cryo-EM analysis. b . Motion-corrected and denoised micrograph of PPAT–NUDT5–AMP complex. c . Representative 2D class averages for PPAT–NUDT5–AMP complex. Micrographs and 2D class averages from the <t>6-meTIMP</t> and 6-benzylTIMP datasets were highly similar to that of the AMP-bound dataset. d , e . SEC and Coomassie-stained gels of PPAT–NUDT5 complexes formed in the presence of d . 6-meTIMP and e . 6-benzylTIMP. f . Cryo-EM data processing particle flow for the three nucleotide-bound PPAT–NUDT5 structures. All processing steps were performed in cryoSPARC. g – i . Angular distribution of particles and FSC curves from refinements of PPAT–NUDT5–purine complexes with g . AMP, h . 6-meTIMP and i . 6-benzylTIMP.
    Imp 3, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/imp/IGF2BP3+Polyclonal+Antibody/pm42809730-51-8-13
    Average 94 stars, based on 1 article reviews
    imp 3 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    ABclonal Biotechnology inosine monophosphate dehydrogenase 2
    ( A – D ) Representative immunohistochemical images showing expression of ADSS1 ( A ) and <t>IMPDH2</t> ( B ) in the induced membrane. Quantification of ADSS1 ( C ) and IMPDH2 ( D ) staining using ImageJ. Each dot represents one animal (IM, n = 6; BD, n = 6). Data are presented as area fraction and normalized to DAPI areas. Box plots represent the median (line), interquartile range (box), and minimum to maximum values (whiskers). P < 0.05 was considered statistically significant. ( E ) Summary of showing alterations in serum and induced membrane at week 6 in IMT rats. Scale bars: 50 μm. ADSS1, adenylosuccinate synthase 1; IMPDH2, inosine monophosphate dehydrogenase 2; BD, bone defect; IM, induced membrane.
    Inosine Monophosphate Dehydrogenase 2, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/imp/IMPDH2+Rabbit+pAb/pmc13461154-234-14-23
    Average 94 stars, based on 1 article reviews
    inosine monophosphate dehydrogenase 2 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    InvivoGen synthetic ligand analog 3 3 cyclic adenine monophosphate inosine monophosphate
    ( A – D ) Representative immunohistochemical images showing expression of ADSS1 ( A ) and <t>IMPDH2</t> ( B ) in the induced membrane. Quantification of ADSS1 ( C ) and IMPDH2 ( D ) staining using ImageJ. Each dot represents one animal (IM, n = 6; BD, n = 6). Data are presented as area fraction and normalized to DAPI areas. Box plots represent the median (line), interquartile range (box), and minimum to maximum values (whiskers). P < 0.05 was considered statistically significant. ( E ) Summary of showing alterations in serum and induced membrane at week 6 in IMT rats. Scale bars: 50 μm. ADSS1, adenylosuccinate synthase 1; IMPDH2, inosine monophosphate dehydrogenase 2; BD, bone defect; IM, induced membrane.
    Synthetic Ligand Analog 3 3 Cyclic Adenine Monophosphate Inosine Monophosphate, supplied by InvivoGen, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/imp/cAIMP/pm42237861-59-9-17
    Average 94 stars, based on 1 article reviews
    synthetic ligand analog 3 3 cyclic adenine monophosphate inosine monophosphate - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Novartis imp 701
    ( A – D ) Representative immunohistochemical images showing expression of ADSS1 ( A ) and <t>IMPDH2</t> ( B ) in the induced membrane. Quantification of ADSS1 ( C ) and IMPDH2 ( D ) staining using ImageJ. Each dot represents one animal (IM, n = 6; BD, n = 6). Data are presented as area fraction and normalized to DAPI areas. Box plots represent the median (line), interquartile range (box), and minimum to maximum values (whiskers). P < 0.05 was considered statistically significant. ( E ) Summary of showing alterations in serum and induced membrane at week 6 in IMT rats. Scale bars: 50 μm. ADSS1, adenylosuccinate synthase 1; IMPDH2, inosine monophosphate dehydrogenase 2; BD, bone defect; IM, induced membrane.
    Imp 701, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/imp/imp701/us12599660-1238-13-15
    Average 86 stars, based on 1 article reviews
    imp 701 - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant human impdh1
    ( A – D ) Representative immunohistochemical images showing expression of ADSS1 ( A ) and <t>IMPDH2</t> ( B ) in the induced membrane. Quantification of ADSS1 ( C ) and IMPDH2 ( D ) staining using ImageJ. Each dot represents one animal (IM, n = 6; BD, n = 6). Data are presented as area fraction and normalized to DAPI areas. Box plots represent the median (line), interquartile range (box), and minimum to maximum values (whiskers). P < 0.05 was considered statistically significant. ( E ) Summary of showing alterations in serum and induced membrane at week 6 in IMT rats. Scale bars: 50 μm. ADSS1, adenylosuccinate synthase 1; IMPDH2, inosine monophosphate dehydrogenase 2; BD, bone defect; IM, induced membrane.
    Recombinant Human Impdh1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/imp/Recombinant+Human+IMP+Dehydrogenase+1%2FIMPDH1+Protein%2C+CF/pm41962611-50-0-12
    Average 93 stars, based on 1 article reviews
    recombinant human impdh1 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    R&D Systems impdh2
    ( A – D ) Representative immunohistochemical images showing expression of ADSS1 ( A ) and <t>IMPDH2</t> ( B ) in the induced membrane. Quantification of ADSS1 ( C ) and IMPDH2 ( D ) staining using ImageJ. Each dot represents one animal (IM, n = 6; BD, n = 6). Data are presented as area fraction and normalized to DAPI areas. Box plots represent the median (line), interquartile range (box), and minimum to maximum values (whiskers). P < 0.05 was considered statistically significant. ( E ) Summary of showing alterations in serum and induced membrane at week 6 in IMT rats. Scale bars: 50 μm. ADSS1, adenylosuccinate synthase 1; IMPDH2, inosine monophosphate dehydrogenase 2; BD, bone defect; IM, induced membrane.
    Impdh2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/imp/Recombinant+Human+IMP+Dehydrogenase+2%2FIMPDH2+Protein%2C+CF/pm41962611-50-6-12
    Average 93 stars, based on 1 article reviews
    impdh2 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    Image Search Results


    a . Size exclusion chromatography (SEC) trace (left) and Coomassie-stained gel of PPAT–NUDT5–AMP complex (right) used for cryo-EM analysis. b . Motion-corrected and denoised micrograph of PPAT–NUDT5–AMP complex. c . Representative 2D class averages for PPAT–NUDT5–AMP complex. Micrographs and 2D class averages from the 6-meTIMP and 6-benzylTIMP datasets were highly similar to that of the AMP-bound dataset. d , e . SEC and Coomassie-stained gels of PPAT–NUDT5 complexes formed in the presence of d . 6-meTIMP and e . 6-benzylTIMP. f . Cryo-EM data processing particle flow for the three nucleotide-bound PPAT–NUDT5 structures. All processing steps were performed in cryoSPARC. g – i . Angular distribution of particles and FSC curves from refinements of PPAT–NUDT5–purine complexes with g . AMP, h . 6-meTIMP and i . 6-benzylTIMP.

    Journal: Nature

    Article Title: Metabolite glues as a means of purine sensing and chemotherapeutic response

    doi: 10.1038/s41586-026-10790-3

    Figure Lengend Snippet: a . Size exclusion chromatography (SEC) trace (left) and Coomassie-stained gel of PPAT–NUDT5–AMP complex (right) used for cryo-EM analysis. b . Motion-corrected and denoised micrograph of PPAT–NUDT5–AMP complex. c . Representative 2D class averages for PPAT–NUDT5–AMP complex. Micrographs and 2D class averages from the 6-meTIMP and 6-benzylTIMP datasets were highly similar to that of the AMP-bound dataset. d , e . SEC and Coomassie-stained gels of PPAT–NUDT5 complexes formed in the presence of d . 6-meTIMP and e . 6-benzylTIMP. f . Cryo-EM data processing particle flow for the three nucleotide-bound PPAT–NUDT5 structures. All processing steps were performed in cryoSPARC. g – i . Angular distribution of particles and FSC curves from refinements of PPAT–NUDT5–purine complexes with g . AMP, h . 6-meTIMP and i . 6-benzylTIMP.

    Article Snippet: NUDT5 (75 μM) was incubated with PPAT (15 μM) directly after elution of PPAT from Strep-Tactin resin for 1 h in 2 ml Strep-Tactin elution buffer (50 mM HEPES-NaOH pH 7.5, 150 mM NaCl, 1 mM DTT and 50 mM biotin) supplemented with 200 μM 6-meTIMP (Jena Biosciences, NU-1226) or 6-benzylTIMP (WuXi).

    Techniques: Size-exclusion Chromatography, Staining, Cryo-Electron Microscopy, Analysis, SDS Page, Single Particle

    a , Metabolism of 6-MP and 6-TG. Orange asterisk indicates 6-TGMP conversion to 6-meTGMP, which is a PPAT–NUDT5 glue. b , AMP and 6-meTIMP structures. c , Left, alignment of the AMP and 6-meTIMP glue interface with cryo-EM density. Right, PPAT residue rearrangement in 6-meTIMP-bound (dark) versus AMP-bound (light) structures. d , PPAT hydrophobic pocket engaged by 6-meTIMP. e , 6-meTIMP glue interface. f , PPAT activity assay with wild-type NUDT5 and nucleotide (0.25 mM PRPP). Data are mean ± s.e.m. from n = 3 independent experiments ( n = 2 for 6-TIMP). g , PRPP-induced PPAT–NUDT5 dissociation (AlphaLisa) with AMP and 6-meTIMP. Data are mean ± s.e.m. from n = 3 independent experiments. Data are also shown in Fig. . h , NUDT5–3×Flag immunoprecipitation (left) and quantification (right) after treatment with MTX (2 µM) and/or 6-MP (50 µM). Data are mean ± s.e.m. with individual values from n = 3 independent biological replicate experiments. i , AMP (M+2) and GMP (M+3) fractional enrichment in [ 15 N-amide]-glutamine labelling of cells treated with 6-MP. Data are mean ± s.e.m. with individual values from n = 6 biological replicates from 2 independent experiments. j , FACS growth competition: ∆NUDT5 and NUDT5 L217A/L218A (LKAA) mutants versus wild-type HEK293T cells treated with 6-MP or 6-TG. Data are mean with individual values from n = 3 biological replicates. k , Viability of wild-type, ∆NUDT5 and NUDT5 L217A/L218A ALL cells treated with 6-meTIMP. Data are mean ± s.e.m. of n = 6 biological replicates from 3 independent experiments. FC (fold change) is the ratio of mutant to wild-type IC 50 . K i and IC 50 values in f , g , k were compared by global nonlinear regression using an extra sum-of-squares F-test. Significance was determined by two-tailed one-sample t -test relative to DMSO control in h and by one-way ANOVA followed by Dunnett’s multiple-comparisons test against wild type in i . NS, not significant. * P < 0.05 and *** P < 0.001. Exact P values are included as source data.

    Journal: Nature

    Article Title: Metabolite glues as a means of purine sensing and chemotherapeutic response

    doi: 10.1038/s41586-026-10790-3

    Figure Lengend Snippet: a , Metabolism of 6-MP and 6-TG. Orange asterisk indicates 6-TGMP conversion to 6-meTGMP, which is a PPAT–NUDT5 glue. b , AMP and 6-meTIMP structures. c , Left, alignment of the AMP and 6-meTIMP glue interface with cryo-EM density. Right, PPAT residue rearrangement in 6-meTIMP-bound (dark) versus AMP-bound (light) structures. d , PPAT hydrophobic pocket engaged by 6-meTIMP. e , 6-meTIMP glue interface. f , PPAT activity assay with wild-type NUDT5 and nucleotide (0.25 mM PRPP). Data are mean ± s.e.m. from n = 3 independent experiments ( n = 2 for 6-TIMP). g , PRPP-induced PPAT–NUDT5 dissociation (AlphaLisa) with AMP and 6-meTIMP. Data are mean ± s.e.m. from n = 3 independent experiments. Data are also shown in Fig. . h , NUDT5–3×Flag immunoprecipitation (left) and quantification (right) after treatment with MTX (2 µM) and/or 6-MP (50 µM). Data are mean ± s.e.m. with individual values from n = 3 independent biological replicate experiments. i , AMP (M+2) and GMP (M+3) fractional enrichment in [ 15 N-amide]-glutamine labelling of cells treated with 6-MP. Data are mean ± s.e.m. with individual values from n = 6 biological replicates from 2 independent experiments. j , FACS growth competition: ∆NUDT5 and NUDT5 L217A/L218A (LKAA) mutants versus wild-type HEK293T cells treated with 6-MP or 6-TG. Data are mean with individual values from n = 3 biological replicates. k , Viability of wild-type, ∆NUDT5 and NUDT5 L217A/L218A ALL cells treated with 6-meTIMP. Data are mean ± s.e.m. of n = 6 biological replicates from 3 independent experiments. FC (fold change) is the ratio of mutant to wild-type IC 50 . K i and IC 50 values in f , g , k were compared by global nonlinear regression using an extra sum-of-squares F-test. Significance was determined by two-tailed one-sample t -test relative to DMSO control in h and by one-way ANOVA followed by Dunnett’s multiple-comparisons test against wild type in i . NS, not significant. * P < 0.05 and *** P < 0.001. Exact P values are included as source data.

    Article Snippet: NUDT5 (75 μM) was incubated with PPAT (15 μM) directly after elution of PPAT from Strep-Tactin resin for 1 h in 2 ml Strep-Tactin elution buffer (50 mM HEPES-NaOH pH 7.5, 150 mM NaCl, 1 mM DTT and 50 mM biotin) supplemented with 200 μM 6-meTIMP (Jena Biosciences, NU-1226) or 6-benzylTIMP (WuXi).

    Techniques: Cryo-Electron Microscopy, Residue, Activity Assay, Immunoprecipitation, Mutagenesis, Two Tailed Test, Control, Mass Spectrometry, Western Blot, Co-Immunoprecipitation Assay, Enzymatic Assay

    a . FACS-based growth competition comparing Δ NUDT5 and rescue mutants with wild-type HEK293T cells treated with 6-TG. Data represent the mean with individual values from n = 3 biological replicates. b . Cryo-EM density of the PPAT–NUDT5 6-meTIMP molecular-glue interface with model fit. c , d . PPAT activity assay measuring inhibitory effects of 6-meTIMP in the absence and presence of wild-type NUDT5 and indicated mutants ( c ) and compared to AMP only ( d ) with 0.25 mM PRPP. Data represent the mean ± s.e.m. from n = 3 independent experiments. e . AlphaLisa binding assay quantifying the stabilization of PPAT–NUDT5 binding by AMP and 6-meTIMP in the presence of PRPP (1 mM). Data represent the mean ± s.e.m. from n = 3 independent experiments. Data for the AMP condition are also shown in Extended Data Fig. . f . Western blot of endogenous PPAT–3×Flag immunoprecipitations after 16-h treatment with MTX (2 µM), 6-MP (50 µM) and MTX + 6-MP. Blot is representative of two independent experiments g . Time-resolved microscopy (incucyte) growth assays of wild-type and mutant HEK293T cells treated with the indicated drugs. Data represent the mean ± s.e.m. of n = 6 biological replicates. h . Levels of intracellular 6-TIMP and 6-meTIMP metabolites after 16-h treatment with 6-MP (20 µM). Data represent the mean ± s.e.m. with individual values from n = 3 biological replicates. i . PPAT activity assay measuring inhibitory effects of 6-meTGMP in the absence and presence of wild-type NUDT5 and mutants. Data represent the mean ± s.e.m. from n = 3 independent experiments. K i values in c , d , i as well as EC 50 in e were compared by global nonlinear regression using an extra sum-of-squares F-test. Statistical significance in h was determined by one-way ANOVA followed by Dunnett’s multiple-comparisons test against wild type. Significance is indicated as ns (not significant), * P < 0.05, ** P < 0.01 and *** P < 0.001. Exact P values are included as source data.

    Journal: Nature

    Article Title: Metabolite glues as a means of purine sensing and chemotherapeutic response

    doi: 10.1038/s41586-026-10790-3

    Figure Lengend Snippet: a . FACS-based growth competition comparing Δ NUDT5 and rescue mutants with wild-type HEK293T cells treated with 6-TG. Data represent the mean with individual values from n = 3 biological replicates. b . Cryo-EM density of the PPAT–NUDT5 6-meTIMP molecular-glue interface with model fit. c , d . PPAT activity assay measuring inhibitory effects of 6-meTIMP in the absence and presence of wild-type NUDT5 and indicated mutants ( c ) and compared to AMP only ( d ) with 0.25 mM PRPP. Data represent the mean ± s.e.m. from n = 3 independent experiments. e . AlphaLisa binding assay quantifying the stabilization of PPAT–NUDT5 binding by AMP and 6-meTIMP in the presence of PRPP (1 mM). Data represent the mean ± s.e.m. from n = 3 independent experiments. Data for the AMP condition are also shown in Extended Data Fig. . f . Western blot of endogenous PPAT–3×Flag immunoprecipitations after 16-h treatment with MTX (2 µM), 6-MP (50 µM) and MTX + 6-MP. Blot is representative of two independent experiments g . Time-resolved microscopy (incucyte) growth assays of wild-type and mutant HEK293T cells treated with the indicated drugs. Data represent the mean ± s.e.m. of n = 6 biological replicates. h . Levels of intracellular 6-TIMP and 6-meTIMP metabolites after 16-h treatment with 6-MP (20 µM). Data represent the mean ± s.e.m. with individual values from n = 3 biological replicates. i . PPAT activity assay measuring inhibitory effects of 6-meTGMP in the absence and presence of wild-type NUDT5 and mutants. Data represent the mean ± s.e.m. from n = 3 independent experiments. K i values in c , d , i as well as EC 50 in e were compared by global nonlinear regression using an extra sum-of-squares F-test. Statistical significance in h was determined by one-way ANOVA followed by Dunnett’s multiple-comparisons test against wild type. Significance is indicated as ns (not significant), * P < 0.05, ** P < 0.01 and *** P < 0.001. Exact P values are included as source data.

    Article Snippet: NUDT5 (75 μM) was incubated with PPAT (15 μM) directly after elution of PPAT from Strep-Tactin resin for 1 h in 2 ml Strep-Tactin elution buffer (50 mM HEPES-NaOH pH 7.5, 150 mM NaCl, 1 mM DTT and 50 mM biotin) supplemented with 200 μM 6-meTIMP (Jena Biosciences, NU-1226) or 6-benzylTIMP (WuXi).

    Techniques: Cryo-Electron Microscopy, Activity Assay, Binding Assay, Western Blot, Microscopy, Mutagenesis

    a , Chemical structures of 6-meTIMP, 6-benzylthioinosine-5′-monophosphate (6-benzylTIMP) and 6-ethylthioinosine-5′-monophosphate (6-etTIMP). b , PPAT activity assay measuring nucleotide-dependent inhibition in the absence and presence of NUDT5. Data are mean ± s.e.m. from n = 3 independent experiments. The same data for 6-meTIMP are shown in both panels for clarity. c , Structural alignment of the region surrounding the molecular-glue interface for the 6-benzylTIMP- and 6-meTIMP-bound PPAT–NUDT5 structures. Cryo-EM density for the 6-benzylTIMP is shown as a transparent surface. d , Sharpened cryo-EM density of the I422–E436 loop in the 6-benzylTIMP and 6-meTIMP maps shown at the same contour. The dashed oval indicates a region of missing density in the 6-benzylTIMP map that is well-defined in the 6-meTIMP map. e , Viability of wild-type, ∆NUDT5 and endogenous NUDT5 L217/K218A mutant cells treated with 6-etTIMP for 72 h. Data are mean ± s.e.m. of n = 6 biological replicates from 3 independent experiments. FC (fold change) is the ratio of mutant to wild-type IC 50 , representing fold change in 6-etTIMP resistance. Selectivity index (SI) is the ratio of 6-etTIMP to 6-meTIMP fold change relative to wild type, quantifying relative on-target cytotoxicity. An SI greater than 1 is indicative of increased on-target cytotoxicity. f , Model of the NUDT5- and purine- or thiopurine-dependent metabolite-glue mechanism. The double asterisks represent the PPAT hydrophobic pocket. K i and IC 50 values in b , e were compared by global nonlinear regression using an extra sum-of-squares F-test. NS, not significant. *** P < 0.001. Exact P values are included as source data.

    Journal: Nature

    Article Title: Metabolite glues as a means of purine sensing and chemotherapeutic response

    doi: 10.1038/s41586-026-10790-3

    Figure Lengend Snippet: a , Chemical structures of 6-meTIMP, 6-benzylthioinosine-5′-monophosphate (6-benzylTIMP) and 6-ethylthioinosine-5′-monophosphate (6-etTIMP). b , PPAT activity assay measuring nucleotide-dependent inhibition in the absence and presence of NUDT5. Data are mean ± s.e.m. from n = 3 independent experiments. The same data for 6-meTIMP are shown in both panels for clarity. c , Structural alignment of the region surrounding the molecular-glue interface for the 6-benzylTIMP- and 6-meTIMP-bound PPAT–NUDT5 structures. Cryo-EM density for the 6-benzylTIMP is shown as a transparent surface. d , Sharpened cryo-EM density of the I422–E436 loop in the 6-benzylTIMP and 6-meTIMP maps shown at the same contour. The dashed oval indicates a region of missing density in the 6-benzylTIMP map that is well-defined in the 6-meTIMP map. e , Viability of wild-type, ∆NUDT5 and endogenous NUDT5 L217/K218A mutant cells treated with 6-etTIMP for 72 h. Data are mean ± s.e.m. of n = 6 biological replicates from 3 independent experiments. FC (fold change) is the ratio of mutant to wild-type IC 50 , representing fold change in 6-etTIMP resistance. Selectivity index (SI) is the ratio of 6-etTIMP to 6-meTIMP fold change relative to wild type, quantifying relative on-target cytotoxicity. An SI greater than 1 is indicative of increased on-target cytotoxicity. f , Model of the NUDT5- and purine- or thiopurine-dependent metabolite-glue mechanism. The double asterisks represent the PPAT hydrophobic pocket. K i and IC 50 values in b , e were compared by global nonlinear regression using an extra sum-of-squares F-test. NS, not significant. *** P < 0.001. Exact P values are included as source data.

    Article Snippet: NUDT5 (75 μM) was incubated with PPAT (15 μM) directly after elution of PPAT from Strep-Tactin resin for 1 h in 2 ml Strep-Tactin elution buffer (50 mM HEPES-NaOH pH 7.5, 150 mM NaCl, 1 mM DTT and 50 mM biotin) supplemented with 200 μM 6-meTIMP (Jena Biosciences, NU-1226) or 6-benzylTIMP (WuXi).

    Techniques: Activity Assay, Inhibition, Cryo-Electron Microscopy, Mutagenesis

    ( A – D ) Representative immunohistochemical images showing expression of ADSS1 ( A ) and IMPDH2 ( B ) in the induced membrane. Quantification of ADSS1 ( C ) and IMPDH2 ( D ) staining using ImageJ. Each dot represents one animal (IM, n = 6; BD, n = 6). Data are presented as area fraction and normalized to DAPI areas. Box plots represent the median (line), interquartile range (box), and minimum to maximum values (whiskers). P < 0.05 was considered statistically significant. ( E ) Summary of showing alterations in serum and induced membrane at week 6 in IMT rats. Scale bars: 50 μm. ADSS1, adenylosuccinate synthase 1; IMPDH2, inosine monophosphate dehydrogenase 2; BD, bone defect; IM, induced membrane.

    Journal: JCI Insight

    Article Title: Purine metabolism enhances neovascularization of type H vessels in the induced membrane technique

    doi: 10.1172/jci.insight.200820

    Figure Lengend Snippet: ( A – D ) Representative immunohistochemical images showing expression of ADSS1 ( A ) and IMPDH2 ( B ) in the induced membrane. Quantification of ADSS1 ( C ) and IMPDH2 ( D ) staining using ImageJ. Each dot represents one animal (IM, n = 6; BD, n = 6). Data are presented as area fraction and normalized to DAPI areas. Box plots represent the median (line), interquartile range (box), and minimum to maximum values (whiskers). P < 0.05 was considered statistically significant. ( E ) Summary of showing alterations in serum and induced membrane at week 6 in IMT rats. Scale bars: 50 μm. ADSS1, adenylosuccinate synthase 1; IMPDH2, inosine monophosphate dehydrogenase 2; BD, bone defect; IM, induced membrane.

    Article Snippet: The primary antibodies used included adenylosuccinate synthase 1 (ADSS1; A6516, rabbit polyclonal antibody, ABclonal), inosine monophosphate dehydrogenase 2 (IMPDH2; A15626, rabbit polyclonal antibody, ABclonal), CD31 conjugated with Alexa Flour 488 (#42777, clone 89C2, Cell Signaling), and endomucin (EMCN) conjugated with Alexa Flour 555 (BS-4808R-A555, rabbit polyclonal antibody, Bioss).

    Techniques: Immunohistochemical staining, Expressing, Membrane, Staining